STRS Ohio’s Ultragenyx Pharmaceutical RARE Stock Holding History

STRS Ohio’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,205	Closed	-$46.2K	–	2289
2026 Q1	$46.2K	Sell	2,205 -3	-0.1%	-$68	﹤0.01%	1951
2025 Q4	$50.8K	Buy	2,208 +60	+3%	+$1.97K	﹤0.01%	1976
2025 Q3	$64.6K	Buy	2,148 +1	+0%	+$30	﹤0.01%	1950
2025 Q2	$78.1K	Buy	+2,147	New	+$77.4K	﹤0.01%	1936
2021 Q2	–	Sell	-20,700	Closed	-$2.36M	–	2390
2021 Q1	$2.36M	Buy	20,700 +1,800	+10%	+$245K	0.01%	647
2020 Q4	$2.62M	Sell	18,900 -1,400	-7%	-$166K	0.01%	617
2020 Q3	$1.67M	Buy	20,300 +11,700	+136%	+$970K	0.01%	698
2020 Q2	$672K	Buy	8,600 +4,200	+95%	+$278K	﹤0.01%	1100
2020 Q1	$195K	Buy	4,400 +2,700	+159%	+$140K	﹤0.01%	1554
2019 Q4	$72K	Sell	1,700 -800	-32%	-$33K	﹤0.01%	1836
2019 Q3	$106K	Sell	2,500 -3,200	-56%	-$174K	﹤0.01%	1756
2019 Q2	$361K	Hold	5,700	–	–	﹤0.01%	1471
2019 Q1	$395K	Buy	5,700 +4,000	+235%	+$229K	﹤0.01%	1420
2018 Q4	$73K	Sell	1,700 -3,800	-69%	-$208K	﹤0.01%	1818
2018 Q3	$419K	Hold	5,500	–	–	﹤0.01%	1459
2018 Q2	$422K	Buy	5,500 +4,300	+358%	+$278K	﹤0.01%	1452
2018 Q1	$61K	Buy	+1,200	New	+$60.4K	﹤0.01%	1706
2017 Q4	–	Sell	-300	Closed	-$15K	–	1926
2017 Q3	$15K	Sell	300 -2,800	-90%	-$166K	﹤0.01%	1879
2017 Q2	$192K	Hold	3,100	–	–	﹤0.01%	1533
2017 Q1	$210K	Buy	3,100 +300	+11%	+$22.9K	﹤0.01%	1526
2016 Q4	$196K	Sell	2,800 -1,000	-26%	-$70.9K	﹤0.01%	1553
2016 Q3	$269K	Sell	3,800 -2,500	-40%	-$160K	﹤0.01%	1483
2016 Q2	$308K	Sell	6,300 -8,300	-57%	-$537K	﹤0.01%	1460
2016 Q1	$924K	Sell	14,600 -500	-3%	-$32.7K	﹤0.01%	839
2015 Q4	$1.69M	Hold	15,100	–	–	0.01%	645
2015 Q3	$1.45M	Buy	15,100 +800	+6%	+$91.6K	0.01%	693
2015 Q2	$1.46M	Buy	14,300 +1,000	+8%	+$77.6K	0.01%	692
2015 Q1	$825K	Buy	+13,300	New	+$739K	﹤0.01%	894

Other funds holding RARE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

STRS Ohio's RARE Position: Q2 2026 in Review

STRS Ohio sold out of Ultragenyx Pharmaceutical (RARE) in Q2 2026, closing a stake of 2,205 shares — an estimated $46.2K sold.

STRS Ohio first reported a position in RARE in Q1 2015 and held it in 28 quarters. The position peaked at $2.62M in Q4 2020. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

STRS Ohio reported no remaining Ultragenyx Pharmaceutical position as of Q2 2026 after selling out during the quarter.
STRS Ohio sold 2,205 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $46.2K.
STRS Ohio first reported a position in Ultragenyx Pharmaceutical in Q1 2015 and held it in 28 quarters.
STRS Ohio's Ultragenyx Pharmaceutical position peaked at $2.62M in Q4 2020.
311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.